4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-111286
Chief Medical Officer sold 3,150 shares at $48.26 ($152,019)
- Chief Medical Officer acquired 8,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Patel Naimish · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 1 in the form | +8,125 | 16,293 | D | ||
| 2026-03-16 | Sale : show line 2 in the form | −3,150 | $48.26 | $152,019 | 13,143 | D |
| Open-market sales · 3,150 sh · avg $48.26 · $152,019 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −8,125 | 24,375 | D |
Loading xslF345X05/ownership.xml…